FindTrial
Sign In

Pattern of side effects in patients undergoing Radioactive iodine therapy for Hyperthyroidism and Thyroid cancers

Pattern of Short term Adverse effects in patients undergoing Radioactive Iodine Therapy for Hyperthyroidism and Differentiated Thyroid Carcinoma (DTC)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/03/017913
Enrollment
127
Registered
2019-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C73- Malignant neoplasm of thyroid gland Health Condition 2: E050- Thyrotoxicosis with diffuse goiter

Interventions

None listed

Sponsors

Ancy George
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing radioactive iodine therapy at low dose for hyperthyroidism and moderate, high and very high doses in differentiated thyroid carcinoma Written informed consent

Exclusion criteria

Exclusion criteria: Known case of hematological malignancies Not given informed consent

Design outcomes

Primary

MeasureTime frame
The pattern of short term adverse effects following low, moderate, high and very high doses of radioactive iodine therapy in hyperthyroidism and DTC. The common short term adverse effects include â?? gastritis, sialadenitis, xerostomia, neck pain, thyroiditis, decreased total peripheral count. The severity of haematological abnormalities assessed by blood routine examination. The use of different sialagogues for dry mouth is estimated by questionnaire method. Timepoint: One year—

Secondary

MeasureTime frame
The use of different sialagogues for dry mouth is estimated by questionnaire method. Timepoint: One year—

Countries

India

Contacts

Public ContactDr Annapurna Y

Govt Medical College Kozhikode

annatvm11@yahoo.com8075643615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026